{
  "input": {
    "mode": "build_chain",
    "query": {
      "entity": "Atypical haemolytic uraemic syndrome",
      "relation": "indication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_eculizumab",
          "name": "Eculizumab"
        },
        "mechanism_outline": "",
        "priority": 1.0
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_ravulizumab",
          "name": "Ravulizumab"
        },
        "mechanism_outline": "",
        "priority": 0.95
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_corticosteroids",
          "name": "Corticosteroids"
        },
        "mechanism_outline": "",
        "priority": 0.9
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_mycophenolate_mofetil",
          "name": "Mycophenolate mofetil"
        },
        "mechanism_outline": "",
        "priority": 0.85
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_cyclophosphamide",
          "name": "Cyclophosphamide"
        },
        "mechanism_outline": "",
        "priority": 0.8
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_thrombopoietin_receptor_agonists",
          "name": "Thrombopoietin receptor agonists"
        },
        "mechanism_outline": "",
        "priority": 0.75
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_plasmapheresis",
          "name": "Plasmapheresis"
        },
        "mechanism_outline": "",
        "priority": 0.7
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_anticoagulants",
          "name": "Anticoagulants"
        },
        "mechanism_outline": "",
        "priority": 0.6499999999999999
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_aspirin",
          "name": "Aspirin"
        },
        "mechanism_outline": "",
        "priority": 0.6
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_sirolimus",
          "name": "Sirolimus"
        },
        "mechanism_outline": "",
        "priority": 0.55
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_rituximab",
          "name": "Rituximab"
        },
        "mechanism_outline": "",
        "priority": 0.5
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_belatacept",
          "name": "Belatacept"
        },
        "mechanism_outline": "",
        "priority": 0.44999999999999996
      }
    ],
    "tegraph_snapshot": {
      "nodes": [],
      "edges": [],
      "round_index": 3
    },
    "constraints": {
      "require_disjoint_paths": 2,
      "max_new_nodes": 50,
      "max_new_edges": 64,
      "batched": true
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "graph_updates": {
      "add_nodes": [
        {
          "id": "drug_eculizumab",
          "type": "Drug",
          "label": "Eculizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_ravulizumab",
          "type": "Drug",
          "label": "Ravulizumab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_corticosteroids",
          "type": "Drug",
          "label": "Corticosteroids",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_mycophenolate_mofetil",
          "type": "Drug",
          "label": "Mycophenolate mofetil",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_cyclophosphamide",
          "type": "Drug",
          "label": "Cyclophosphamide",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_thrombopoietin_receptor_agonists",
          "type": "Drug",
          "label": "Thrombopoietin receptor agonists",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_plasmapheresis",
          "type": "Drug",
          "label": "Plasmapheresis",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_anticoagulants",
          "type": "Drug",
          "label": "Anticoagulants",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_aspirin",
          "type": "Drug",
          "label": "Aspirin",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_sirolimus",
          "type": "Drug",
          "label": "Sirolimus",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_rituximab",
          "type": "Drug",
          "label": "Rituximab",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "drug_belatacept",
          "type": "Drug",
          "label": "Belatacept",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Target_C5",
          "type": "Target",
          "label": "C5 Complement Protein",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Pathway_complement_system",
          "type": "Pathway",
          "label": "Complement System",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Disease_aHUS",
          "type": "Disease",
          "label": "Atypical Haemolytic Uraemic Syndrome",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_renal_failure",
          "type": "Phenotype",
          "label": "Renal Failure",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "Phenotype_thrombocytopenia",
          "type": "Phenotype",
          "label": "Thrombocytopenia",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "add_edges": [
        {
          "source": "drug_eculizumab",
          "target": "Target_C5",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对C5补体蛋白的靶向作用"
        },
        {
          "source": "drug_ravulizumab",
          "target": "Target_C5",
          "relation": "acts_on",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "针对C5补体蛋白的靶向作用"
        },
        {
          "source": "Target_C5",
          "target": "Pathway_complement_system",
          "relation": "involved_in",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "补体系统的关键成分"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Disease_aHUS",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "补体系统异常与aHUS相关"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Phenotype_renal_failure",
          "relation": "causes",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "与肾功能衰竭的直接关联"
        },
        {
          "source": "Pathway_complement_system",
          "target": "Phenotype_thrombocytopenia",
          "relation": "causes",
          "weight": 0.75,
          "agent": "Proponent",
          "rationale": "与血小板减少症的直接关联"
        },
        {
          "source": "drug_corticosteroids",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于管理相关并发症"
        },
        {
          "source": "drug_mycophenolate_mofetil",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "用于免疫抑制治疗"
        },
        {
          "source": "drug_cyclophosphamide",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "对于免疫相关疾病的治疗"
        },
        {
          "source": "drug_thrombopoietin_receptor_agonists",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "刺激血小板生成的潜在疗法"
        },
        {
          "source": "drug_plasmapheresis",
          "target": "Disease_aHUS",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "血浆置换在aHUS治疗中的应用"
        },
        {
          "source": "drug_anticoagulants",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.55,
          "agent": "Proponent",
          "rationale": "防止血栓形成的处理"
        },
        {
          "source": "drug_aspirin",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "在血小板减少症的辅助使用"
        },
        {
          "source": "drug_sirolimus",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "Proponent",
          "rationale": "用于控制免疫反应"
        },
        {
          "source": "drug_rituximab",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "治疗免疫性疾病"
        },
        {
          "source": "drug_belatacept",
          "target": "Phenotype_thrombocytopenia",
          "relation": "supports",
          "weight": 0.5,
          "agent": "作为免疫抑制剂的应用"
        }
      ],
      "merge": [],
      "set_weights": []
    },
    "subconclusions": [
      {
        "id": "C1",
        "text": "Eculizumab和Ravulizumab通过抑制C5补体影响aHUS的发病机制",
        "confidence": "high"
      },
      {
        "id": "C2",
        "text": "其他药物可作为辅助治疗或管理相关表型",
        "confidence": "medium"
      }
    ],
    "assumptions": [
      "药物对靶器官具有有效的药代动力学特性"
    ],
    "uncertainties": [
      "不同药物组合的最佳效果仍需进一步研究"
    ],
    "next_focus_for_pi": [
      "是否需要探索对C5以外的靶点的药物?"
    ]
  }
}